David Mack

David H.
Mack is the founder of PMV Pharmaceuticals, Inc., founded in 2013, where the titles held are President, Chief Executive Officer & Director.
Dr. Mack is also the founder of EOS Biotechnology, Inc...
Dr. Mack is currently Director at Intradigm Corp.
since 2006, Director at Vitra Bioscience, Inc., and Director at ACMP IV LLC.
Former positions include Chief Executive Officer & Director at Angiosyn, Inc. from 2003 to 2005; Director at Alta Partners Management Co. LP; Director at Proacta, Inc.; Director at Ceregene, Inc.; Independent Director at Aerie Pharmaceuticals, Inc. in 2013; Director at aTyr Pharma, Inc.; Director at Sutro Biopharma, Inc.; Director at Aduro BioTech, Inc. from 2019 to 2020; Non-Executive Director at Silence Therapeutics Plc from 2010 to 2013; Director at Pathwork Diagnostics, Inc.; Director at Proacta Therapeutics Ltd.; Head-Cancer Biology at Affymetrix, Inc. from 1994 to 1997; Member-Polymerase Chain Reaction Invention at Cetus Corp.
Education includes a doctorate from The University of Chicago in 1992 and undergraduate studies at the University of California, Berkeley.